ampelopsin has been researched along with Alloxan Diabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Q; Liu, S; Peng, Q; Wang, J; Zhang, Y | 1 |
| Li, X; Mou, H; Wei, L; Yang, X; Yao, Y | 1 |
| Gao, Y; Ge, H; Guan, S; Hao, Y; He, L; Huang, R; Liu, L; Shen, Y; Sun, M; Xiong, W; Yin, C | 1 |
| Chi, J; Guo, H; Lin, H; Lin, N; Lu, W; Ni, T; Sun, Z | 1 |
| Fan, M; Guo, T; Han, D; Lin, J; Luo, J; Tao, L; Wu, B; Yi, F; Yuan, M | 1 |
| Feng, S; He, J; Liao, D; Ling, H; Wu, D; Yang, J; Yang, S; Zhu, Z | 1 |
| Feng, SD; He, JQ; Ling, HY; Yang, JH; Yang, SS; Zhang, KF; Zhu, ZM | 1 |
| Lang, H; Liu, L; Mi, M; Si, M; Wan, J; Zhou, Y; Zhu, J | 1 |
8 other study(ies) available for ampelopsin and Alloxan Diabetes
| Article | Year |
|---|---|
[Dihydromyricetin improves cardiac insufficiency by inhibiting HMGB1 in diabetic rats].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Heart Failure; HMGB1 Protein; Male; Metformin; NF-kappa B; Rats; Rats, Sprague-Dawley | 2022 |
Dihydromyricetin promotes GLP-1 release and glucose uptake by STC-1 cells and enhances the effects of metformin upon STC-1 cells and diabetic mouse model.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Glucose; Hypoglycemic Agents; Insulin; Metformin; Tea | 2023 |
Dihydromyricetin affects BDNF levels in the nervous system in rats with comorbid diabetic neuropathic pain and depression.
Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Comorbidity; Depression; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Flavonols; Hippocampus; Humans; Male; Pain Measurement; Rats; Receptor, trkB; Signal Transduction; Streptozocin | 2019 |
Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy.
Topics: Animals; Apoptosis; Autophagy; Autophagy-Related Proteins; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Down-Regulation; Flavonols; Male; Mice; MicroRNAs; Myocytes, Cardiac; Rats, Wistar; Signal Transduction; Ventricular Function, Left | 2020 |
Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice.
Topics: Animals; Apoptosis; Autophagy; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Flavonols; Inflammation; Male; Mice; Oxidative Stress | 2017 |
Dihydromyricetin improves type 2 diabetes-induced cognitive impairment via suppressing oxidative stress and enhancing brain-derived neurotrophic factor-mediated neuroprotection in mice.
Topics: Ampelopsis; Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Maze Learning; Mice; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Phytotherapy; Plant Extracts | 2018 |
[The effects of dihydromyricetin on cognitive dysfunction in type 2 diabetes mice].
Topics: Animals; Blood Glucose; Brain-Derived Neurotrophic Factor; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonols; Hippocampus; Learning; Memory; Mice; Mice, Inbred C57BL | 2017 |
Dihydromyricetin delays the onset of hyperglycemia and ameliorates insulin resistance without excessive weight gain in Zucker diabetic fatty rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Progression; Flavonols; Hyperglycemia; Insulin Resistance; Male; Obesity; Rats; Rats, Zucker; Time Factors; Weight Gain | 2017 |